210 related articles for article (PubMed ID: 37490175)
21. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data.
Méndez-Sánchez N; Villa AR; Chávez-Tapia NC; Ponciano-Rodriguez G; Almeda-Valdés P; González D; Uribe M
Ann Hepatol; 2005; 4(1):52-5. PubMed ID: 15798662
[TBL] [Abstract][Full Text] [Related]
22. Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis.
Behari J; Gougol A; Wang R; Luu HN; Paragomi P; Yu YC; Molinari M; Chopra K; Malik SM; Geller D; Yuan JM
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37395730
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of non-alcoholic fatty liver disease in Asia.
Wong SW; Chan WK
Indian J Gastroenterol; 2020 Feb; 39(1):1-8. PubMed ID: 32152903
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular cancer in Sweden: incidence 1961-1962 and 1971-1972.
Axelsson G
J Chronic Dis; 1982; 35(6):459-66. PubMed ID: 6281291
[TBL] [Abstract][Full Text] [Related]
25. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis.
Phan J; Ng V; Sheinbaum A; French S; Choi G; El Kabany M; Durazo F; Saab S; Tong M; Busuttil R; Han SH
J Clin Gastroenterol; 2019 Apr; 53(4):309-313. PubMed ID: 29912756
[TBL] [Abstract][Full Text] [Related]
26. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.
Pais R; Fartoux L; Goumard C; Scatton O; Wendum D; Rosmorduc O; Ratziu V
Aliment Pharmacol Ther; 2017 Nov; 46(9):856-863. PubMed ID: 28857208
[TBL] [Abstract][Full Text] [Related]
27. Study of liver cirrhosis over ten consecutive years in Southern China.
Wang X; Lin SX; Tao J; Wei XQ; Liu YT; Chen YM; Wu B
World J Gastroenterol; 2014 Oct; 20(37):13546-55. PubMed ID: 25309085
[TBL] [Abstract][Full Text] [Related]
28. Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.
Marengo A; Jouness RI; Bugianesi E
Clin Liver Dis; 2016 May; 20(2):313-24. PubMed ID: 27063271
[TBL] [Abstract][Full Text] [Related]
29. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
[TBL] [Abstract][Full Text] [Related]
30. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766
[TBL] [Abstract][Full Text] [Related]
31. The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population-based cohort study.
Bengtsson B; Widman L; Wahlin S; Stål P; Björkström NK; Hagström H
United European Gastroenterol J; 2022 Jun; 10(5):465-476. PubMed ID: 35491484
[TBL] [Abstract][Full Text] [Related]
32. [Alcoholic liver diseases and hepatitis virus C in Japan].
Horie Y; Yamagishi Y; Kato S; Kikuchi M; Ishii H; Hibi T
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Oct; 41(5):424-30. PubMed ID: 17176848
[TBL] [Abstract][Full Text] [Related]
33. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
[TBL] [Abstract][Full Text] [Related]
34. Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based study.
Flemming JA; Dewit Y; Mah JM; Saperia J; Groome PA; Booth CM
Lancet Gastroenterol Hepatol; 2019 Mar; 4(3):217-226. PubMed ID: 30573390
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
[TBL] [Abstract][Full Text] [Related]
36. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
[TBL] [Abstract][Full Text] [Related]
37. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
[TBL] [Abstract][Full Text] [Related]
38. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.
Moon AM; Singal AG; Tapper EB
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2650-2666. PubMed ID: 31401364
[TBL] [Abstract][Full Text] [Related]
39. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
Bertot LC; Adams LA
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
[TBL] [Abstract][Full Text] [Related]
40. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
Dhamija E; Paul SB; Kedia S
Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
